British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company ...

Barclays analyst Iain Simpson maintained a Buy rating on Haleon PLC (HLN – Research Report) today and set a price target of £4.45. The ...

Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the ...

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.

In a report released on February 27, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a ...

Haleon PLC HLN shares slipped 3.31% to £3.82 Thursday, on what proved to be an all-around favorable trading session for the ...

Haleon plc misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $25.25. Jo Russell: Good morning, everyone. Welcome to Haleon’s Full Year 2024 Q&A call. I’m Jo Russell ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...